Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Davide Gatti, Maurizio Rossini, Ombretta Viapiana, Luca Idolazzi & Silvano Adami. (2013) Clinical development of neridronate: potential for new applications. Therapeutics and Clinical Risk Management 9, pages 139-147.
Read now
Read now
Articles from other publishers (29)
Qiuyao Wu, Pu Tian, Dasa He, Zhenchang Jia, Yunfei He, Wenqian Luo, Xianzhe Lv, Yuan Wang, Peiyuan Zhang, Yajun Liang, Wenjin Zhao, Jun Qin, Peng Su, Yi-Zhou Jiang, Zhi-Ming Shao, Qifeng Yang & Guohong Hu. (2023) SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches. Cell Research 33:6, pages 464-478.
Crossref
Crossref
Mohammed Tanjimur Rahman, Youzhi Kaung, Logan Shannon, Charlie Androjna, Nima Sharifi & Vinod Labhasetwar. (2023) Nanoparticle-mediated synergistic drug combination for treating bone metastasis. Journal of Controlled Release 357, pages 498-510.
Crossref
Crossref
Gabriel M. Pagnotti, Trupti Trivedi & Khalid S. Mohammad. (2022) Translational Strategies to Target Metastatic Bone Disease. Cells 11:8, pages 1309.
Crossref
Crossref
Robert L. Satcher & Xiang H.-F. Zhang. (2021) Evolving cancer–niche interactions and therapeutic targets during bone metastasis. Nature Reviews Cancer 22:2, pages 85-101.
Crossref
Crossref
Aaron M. Muscarella, Sergio Aguirre, Xiaoxin Hao, Sarah M. Waldvogel & Xiang H.-F. Zhang. (2021) Exploiting bone niches: progression of disseminated tumor cells to metastasis. Journal of Clinical Investigation 131:6.
Crossref
Crossref
Marissa B. Serafin, Angelita Bottega, Taciéli F. da Rosa, Catrine S. Machado, Vitória S. Foletto, Silvana S. Coelho, Augusto D. da Mota & Rosmari Hörner. (2021) Drug Repositioning in Oncology. American Journal of Therapeutics 28:1, pages e111-e117.
Crossref
Crossref
Yung-Chieh Chang, Chun Hei Antonio Cheung & Yao-Lung Kuo. (2020) Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Hai Wang, Weijie Zhang, Igor Bado & Xiang H.-F. Zhang. 2020. Encyclopedia of Bone Biology. Encyclopedia of Bone Biology
78
95
.
Hai Wang, Lin Tian, Jun Liu, Amit Goldstein, Igor Bado, Weijie Zhang, Benjamin R. Arenkiel, Zonghai Li, Meng Yang, Shiyu Du, Hong Zhao, David R. Rowley, Stephen T.C. Wong, Zbigniew Gugala & Xiang H.-F. Zhang. (2018) The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability. Cancer Cell 34:5, pages 823-839.e7.
Crossref
Crossref
Katie A. Edwards, Joshua J. Havelin, Mary I. Mcintosh, Haley A. Ciccone, Kathlene Pangilinan, Ian Imbert, Tally M. Largent-Milnes, Tamara King, Todd W. Vanderah & John M. Streicher. (2018) A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. The Journal of Pain 19:6, pages 612-625.
Crossref
Crossref
Yibin Kang. (2016) Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis. Endocrinology and Metabolism 31:2, pages 206.
Crossref
Crossref
Haoran Li, Xiaohua Wu & Xi Cheng. (2016) Advances in diagnosis and treatment of metastatic cervical cancer. Journal of Gynecologic Oncology 27:4.
Crossref
Crossref
. 2016. Diagnostic Imaging: Nuclear Medicine. Diagnostic Imaging: Nuclear Medicine
408
411
.
. 2016. Diagnostic Imaging: Nuclear Medicine. Diagnostic Imaging: Nuclear Medicine
136
141
.
Arjun S. Sebastian, Marcus J. Adair, Jonathan M. Morris, Mustafa H. Khan, Carola A. S. Arndt & Ahmad Nassr. (2014) Minimally Invasive Treatment of a Painful Osteolytic Lumbar Lesion Secondary to Epithelioid Hemangioendothelioma. Global Spine Journal 5:2, pages 135-139.
Crossref
Crossref
Juraj Kavecansky, Lai Wei, Lisa Caronia, Maria-Teresa Ramirez, Mark Bloomston & Manisha H. Shah. (2015) Bone Metastases in Well-to-Moderately Differentiated Neuroendocrine Tumors. Pancreas 44:2, pages 198-203.
Crossref
Crossref
Hai Wang, Cuijuan Yu, Xia Gao, Thomas Welte, Aaron M. Muscarella, Lin Tian, Hong Zhao, Zhen Zhao, Shiyu Du, Jianning Tao, Brendan Lee, Thomas F. Westbrook, Stephen T.C. Wong, Xin Jin, Jeffrey M. Rosen, C. Kent Osborne & Xiang H.-F. Zhang. (2015) The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells. Cancer Cell 27:2, pages 193-210.
Crossref
Crossref
James R. Berenson. (2014) Bone-targeted therapies for cancer patients and bone cell biology. Current Opinion in Supportive & Palliative Care 8:4, pages 405-406.
Crossref
Crossref
Zanjing Zhai, Xinhua Qu, Wei Yan, Haowei Li, Guangwang Liu, Xuqiang Liu, Tingting Tang, An Qin & Kerong Dai. (2014) Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling. Breast Cancer Research and Treatment 144:1, pages 33-45.
Crossref
Crossref
Aera Yoon, Chel Hun Choi, Tae-Hyun Kim, June-Kuk Choi, Jin-Young Park, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae & Byoung-Gie Kim. (2014) Bone Metastasis in Primary Endometrial Carcinoma. International Journal of Gynecological Cancer 24:1, pages 107-112.
Crossref
Crossref
Dareen M. Abdelaziz, Laura S. Stone & Svetlana V. Komarova. (2013) Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin. Breast Cancer Research and Treatment 143:2, pages 227-237.
Crossref
Crossref
Elizabeth Rommer, Solmaz Niknam Leilabadi, Grace Lam, Ali Soltani, Chandra V. Ellis, Murtaza Rizvi & Alex K. Wong. (2013) Metastasis of Hepatocellular and Renal Cell Carcinoma to the Hand. Plastic and Reconstructive Surgery Global Open 1:9, pages e83.
Crossref
Crossref
Motoho Morita, Tetsuya Higuchi, Arifudin Achmad, Azusa Tokue, Yukiko Arisaka & Yoshito Tsushima. (2013) Complementary roles of tumour specific PET tracer 18F-FAMT to 18F-FDG PET/CT for the assessment of bone metastasis. European Journal of Nuclear Medicine and Molecular Imaging 40:11, pages 1672-1681.
Crossref
Crossref
Aera Yoon, Chel Hun Choi, Ha-Jeong Kim, Jin-Young Park, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae & Byoung-Gie Kim. (2013) Contributing Factors for Bone Metastasis in Uterine Cervical Cancer. International Journal of Gynecological Cancer 23:7, pages 1311-1317.
Crossref
Crossref
Subash C. Gupta, Bokyung Sung, Sahdeo Prasad, Lauren J. Webb & Bharat B. Aggarwal. (2013) Cancer drug discovery by repurposing: teaching new tricks to old dogs. Trends in Pharmacological Sciences 34:9, pages 508-517.
Crossref
Crossref
Evangelos Terpos & Dimitrios Christoulas. (2013) Effects of proteasome inhibitors on bone cancer. BoneKEy Reports 2.
Crossref
Crossref
Boris Michael Holzapfel, Laure Thibaudeau, Parisa Hesami, Anna Taubenberger, Nina Pauline Holzapfel, Susanne Mayer-Wagner, Carl Power, Judith Clements, Pamela Russell & Dietmar Werner Hutmacher. (2013) Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism. Cancer and Metastasis Reviews 32:1-2, pages 129-145.
Crossref
Crossref
Tapas Das & M.R.A. Pillai. (2013) Options to meet the future global demand of radionuclides for radionuclide therapy. Nuclear Medicine and Biology 40:1, pages 23-32.
Crossref
Crossref
Shuji Majima, Teiji Wada & Mitsugu Ikeda. (2012) Pharmacological profiles and results of clinical studies of denosumab (RANMARK^|^reg;), a human anti-RANKL antibody. Folia Pharmacologica Japonica 140:6, pages 295-302.
Crossref
Crossref